Breakthrough in Cancer Treatment: Self-Assembled Nanoparticles Show Promise

Researchers at the Chinese Academy of Medical Sciences have made a significant breakthrough in cancer treatment by developing a novel formulation of paclitaxel that exhibits strong anti-tumor effects and safety in combination with immunotherapy. The study, published in Materials Today Bio, demonstrates the potential of self-assembled nanoparticles to enhance cancer immunotherapy.

Key Takeaways:

• The research team developed a novel formulation of paclitaxel, a commonly used cancer medication, by conjugating it with phenylboronic acid and self-assembling it with fructose into nanoparticles (PTX-PBA-Fru NPs).
• The nanoparticles exhibited a uniform size of 107.8 ± 2.9 nm, a polydispersity index (PDI) of 0.064 ± 0.042, and a zeta potential of -12.2 ± 0.9 mV, with spherical morphology.
• In 4T1 tumor-bearing mice, the PTX-PBA-Fru NPs significantly enhanced tumor inhibition (p
• Chinese Academy of Medical Sciences. (n.d.). Retrieved from